Canada - français - Health Canada

bio vita - séné; cascara sagrada; réglisse; rhubarbe - comprimé - 240mg; 150mg; 30mg; 8mg - séné 240mg; cascara sagrada 150mg; réglisse 30mg; rhubarbe 8mg - cathartics and laxatives

Union européenne - français - EMA (European Medicines Agency)

amgen europe b.v. - adalimumab - arthritis, psoriatic; colitis, ulcerative; arthritis, juvenile rheumatoid; spondylitis, ankylosing; psoriasis; crohn disease; arthritis, rheumatoid - immunosuppresseurs - rheumatoid arthritis  amgevita in combination with methotrexate, is indicated for: , the treatment of moderate to severe, active rheumatoid arthritis in adult patients when the response to disease-modifying anti-rheumatic drugs including methotrexate has been inadequate. le traitement de sévère, active et progressive de la polyarthrite rhumatoïde chez les adultes non précédemment traités par le méthotrexate. ,  amgevita can be given as monotherapy in case of intolerance to methotrexate or when continued treatment with methotrexate is inappropriate. amgevita réduit le taux de progression des lésions articulaires mesurés par radiographie et améliore la fonction physique, lorsqu'il est administré en association avec le méthotrexate. juvenile idiopathic arthritis polyarticular juvenile idiopathic arthritis amgevita in combination with methotrexate is indicated for the treatment of active polyarticular juvenile idiopathic arthritis, in patients from the age of 2 years who have had an inadequate response to one or more disease-modifying anti-rheumatic drugs (dmards). amgevita peut être administré en monothérapie en cas d'intolérance au méthotrexate ou lorsque la poursuite du traitement avec le méthotrexate, est inadéquate (pour l'efficacité en monothérapie, voir la section 5. l'adalimumab n'a pas été étudié chez les patients âgés de moins de 2 ans. enthesitis-related arthritis amgevita is indicated for the treatment of active enthesitis-related arthritis in patients, 6 years of age and older, who have had an inadequate response to, or who are intolerant of, conventional therapy (see section 5. axial spondyloarthritis ankylosing spondylitis (as) amgevita is indicated for the treatment of adults with severe active ankylosing spondylitis who have had an inadequate response to conventional therapy. axial spondyloarthritis without radiographic evidence of as amgevita is indicated for the treatment of adults with severe axial spondyloarthritis without radiographic evidence of as but with objective signs of inflammation by elevated crp and/or mri, who have had an inadequate response to, or are intolerant to non-steroidal anti-inflammatory drugs. psoriatic arthritis amgevita is indicated for the treatment of active and progressive psoriatic arthritis in adults when the response to previous disease-modifying anti-rheumatic drug therapy has been inadequate. amgevita réduit le taux de progression de l'atteinte articulaire périphérique tel que mesuré par rayons x dans les patients avec polyarticular symétrique sous-types de la maladie (voir la section 5. 1) et améliore la fonction physique. psoriasis amgevita is indicated for the treatment of moderate to severe chronic plaque psoriasis in adult patients who are candidates for systemic therapy. paediatric plaque psoriasis amgevita is indicated for the treatment of severe chronic plaque psoriasis in children and adolescents from 4 years of age who have had an inadequate response to or are inappropriate candidates for topical therapy and phototherapies. hidradenitis suppurativa (hs) amgevita is indicated for the treatment of active moderate to severe hidradenitis suppurativa (acne inversa) in adults and adolescents from 12 years of age with an inadequate response to conventional systemic hs therapy (see sections 5. 1 et 5. crohn’s disease amgevita is indicated for treatment of moderately to severely active crohn’s disease, in adult patients who have not responded despite a full and adequate course of therapy with a corticosteroid and/or an immunosuppressant; or who are intolerant to or have medical contraindications for such therapies. paediatric crohn's disease amgevita is indicated for the treatment of moderately to severely active crohn's disease in paediatric patients (from 6 years of age) who have had an inadequate response to conventional therapy including primary nutrition therapy and a corticosteroid and/or an immunomodulator, or who are intolerant to or have contraindications for such therapies. ulcerative colitis amgevita is indicated for treatment of moderately to severely active ulcerative colitis in adult patients who have had an inadequate response to conventional therapy including corticosteroids and 6-mercaptopurine (6-mp) or azathioprine (aza), or who are intolerant to or have medical contraindications for such therapies. uveitis amgevita is indicated for the treatment of non-infectious intermediate, posterior and panuveitis in adult patients who have had an inadequate response to corticosteroids, in patients in need of corticosteroid-sparing, or in whom corticosteroid treatment is inappropriate. paediatric uveitis amgevita is indicated for the treatment of paediatric chronic non-infectious anterior uveitis in patients from 2 years of age who have had an inadequate response to or are intolerant to conventional therapy, or in whom conventional therapy is inappropriate.

Belgique - français - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

will pharma sa-nv - carbonate de calcique 2500 mg - eq. calcium 1000 mg; cholécalciférol 880 ui - granulés effervescents - 1000 mg - 880 iu - cholécalciférol 880 ui; carbonate de calcique 2500 mg - calcium, combinations with vitamin d and/or other drugs

Belgique - français - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

will pharma sa-nv - carbonate de calcique 1250 mg - eq. calcium 500 mg; cholécalciférol 440 ui - granulés effervescents - 500 mg - 440 iu - cholécalciférol 440 ui; carbonate de calcique 1250 mg - calcium, combinations with vitamin d and/or other drugs

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

geistlich pharma ag - retinoli palmitas, cholecalciferolum, int-rac-alpha-tocopherylis acetas, thiamini nitras, riboflavinum, pyridoxini hydrochloridum, cyanocobalaminum, nicotinamidum, dexpanthenolum, l'acide ascorbicum, calcium hydrogenophosphas, de calcium et de magnésium fytas trihydricus, le fer, le cuivre, manganum, l'acide oroticum anhydricum, cholini hydrogenotartras, rutosidum trihydricum - capsules - vitamina: retinoli palmitas 10000 u. i., cholecalciferolum 400 u. i., int-rac-alpha-tocopherylis acetas 15 mg, thiamini nitras 10 mg, riboflavinum 3 mg, pyridoxini hydrochloridum 5 mg, cyanocobalaminum 5 µg, nicotinamidum 10 mg, dexpanthenolum 10 mg, acide ascorbicum 70 mg, minéraux: calcium hydrogenophosphas 85 mg, de calcium et de magnésium fytas trihydricus 50 mg, fer à repasser 10 mg en ferrosi fumaras, cuivre 1 mg de cuivre sulfamidés, manganum 0,5 mg de mangani sulfamidés monohydricus, d'autres: deanoli orotas et de magnésium orotas dihydricus corresp. l'acide oroticum anhydricum 100 mg, cholini hydrogenotartras 50 mg rutosidum trihydricum 10 mg, excipiens pro de la capsule. - la vitamine et de mineralstoffpräparat à mangelzuständen à l'Âge - synthetika

Belgique - français - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

will pharma sa-nv - carbonate de calcique 1250 mg - eq. calcium 500 mg; cholécalciférol 880 ui - eq. vitamine d4 22 µg - granulés effervescents - 500 mg - 880 iu - carbonate de calcique 1250 mg; cholécalciférol 880 ui - calcium, combinations with vitamin d and/or other drugs

Canada - français - Health Canada

institut de recherche biologique yves ponroy canada inc. - vitamine e (d-alpha tocophérol); vitamine b12 (cyanocobalamine); acide folique; calcium (carbonate de calcium) - capsule - 2.6unité; 0.54mcg; 0.08mg; 39mg - vitamine e (d-alpha tocophérol) 2.6unité; vitamine b12 (cyanocobalamine) 0.54mcg; acide folique 0.08mg; calcium (carbonate de calcium) 39mg - vitamins & minerals

Canada - français - Health Canada

apotex inc - acide alendronique (alendronate sodique); vitamine d3 (cholécalciférol) - comprimé - 70mg; 2800unité - acide alendronique (alendronate sodique) 70mg; vitamine d3 (cholécalciférol) 2800unité - vitamin d

Canada - français - Health Canada

apotex inc - acide alendronique (alendronate sodique); vitamine d3 (cholécalciférol) - comprimé - 70mg; 5600unité - acide alendronique (alendronate sodique) 70mg; vitamine d3 (cholécalciférol) 5600unité - vitamin d

Canada - français - Health Canada

bio agri mix lp - vitamine a; vitamine d3; vitamine e; vitamine b12; vitanine b2; nicotinamide; d-pantothénate de calcium; chlorhydrate de thiamine; chlorhydrate de pyridoxine; sulfite acide de ménadione sodique; acide folique; acide ascorbique; biotine; chlorure de potassium; chlorure de sodium - poudre pour solution - 2566000unité; 561000unité; 1870unité; 3.74mg; 1.122g; 4.488g; 3.252g; 462.5mg; 448.8mg; 748mg; 112.2mg; 555mg; 18.7mg; 4.25g; 1. - vitamine a 2566000unité; vitamine d3 561000unité; vitamine e 1870unité; vitamine b12 3.74mg; vitanine b2 1.122g; nicotinamide 4.488g; d-pantothénate de calcium 3.252g; chlorhydrate de thiamine 462.5mg; chlorhydrate de pyridoxine 448.8mg; sulfite acide de ménadione sodique 748mg; acide folique 112.2mg; acide ascorbique 555mg; biotine 18.7mg; chlorure de potassium 4.25g; chlorure de sodium 1.7g - bétails; bétails; chevaux; volaille; volaille; porcs